World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
40180
World Ranking
12026
National Ranking
1139

Emad A. Rakha publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Emad A. Rakha sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 622 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Emad A. Rakha D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Emad A. Rakha sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 90 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Emad A. Rakha is affiliated with the University of Nottingham in the United Kingdom and has a focused research profile in the fields of biochemistry, genetics, molecular biology, and medicine. Their work encompasses a substantial number of publications related to cancer research and oncology, emphasizing breast cancer and associated molecular mechanisms.

The scientist's main subfields of study include cancer research, oncology, molecular biology, pathology and forensic medicine, and radiology, nuclear medicine, and imaging. These fields highlight a multidisciplinary approach to cancer diagnosis, treatment, and biological understanding.

Research topics frequently addressed by Emad A. Rakha cover breast cancer treatment studies, breast lesions and carcinomas, cancer genomics and diagnostics, artificial intelligence applications in cancer detection, HER2/EGFR-related cancer research, cancer cell metastasis, and molecular pathways involved in cancer development.

Notable recent publications include:

  • IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis, 2020, Cancer Cell
  • Breast tumor microenvironment structures are associated with genomic features and clinical outcome, 2022, Nature Genetics
  • An update on the pathological classification of breast cancer, 2022, Histopathology
  • Determining breast cancer biomarker status and associated morphological features using deep learning, 2021, Communications Medicine
  • Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer, 2020, British Journal of Cancer

The scientist has collaborated extensively with several frequent co-authors, including Andrew R. Green, Michael S. Toss, Nigel P. Mongan, Ian O. Ellis, and Mansour Alsaleem, reflecting a consistent partnership in breast cancer and cancer biology research.

Emad A. Rakha's work has been published predominantly in several key scientific journals related to pathology and oncology. The most frequent publication venues include Histopathology, Breast Cancer Research and Treatment, Modern Pathology, Cancers, and Cancer Research. These venues indicate a focus on both clinical and molecular aspects of cancer science.

Best Publications

  • Prognostic markers in triple-negative breast cancer

    Emad A. Rakha;Maysa E. El-Sayed;Andrew R. Green;Andrew H. S. Lee

  • Basal-Like Breast Cancer: A Critical Review

    Emad A. Rakha;Jorge S. Reis-Filho;Ian O. Ellis

  • Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

    Fiona M. Blows;Kristy E. Driver;Marjanka K. Schmidt;Annegien Broeks

  • Breast cancer prognostic classification in the molecular era: the role of histological grade

    Emad A. Rakha;Jorge S. Reis-Filho;Frederick Baehner;David J. Dabbs

  • A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.

    Guido Rindi;David S. Klimstra;Behnoush Abedi-Ardekani;Sylvia L. Asa

  • Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

    Sunil Badve;David J. Dabbs;Stuart J. Schnitt;Frederick L. Baehner

  • Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients

    Hamid Ali;E Provenzano;S-J Dawson;FM Blows

  • High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

    Dalia M. Abd El-Rehim;Graham Ball;Sarah E. Pinder;Emad Rakha

  • Prognostic Significance of Nottingham Histologic Grade in Invasive Breast Carcinoma

    Emad A. Rakha;Maysa E. El-Sayed;Andrew H. S. Lee;Christopher W. Elston

  • Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes.

    Emad A. Rakha;Somaia E. Elsheikh;Somaia E. Elsheikh;Muhammed A. Aleskandarany;Muhammed A. Aleskandarany;Hany O. Habashi;Hany O. Habashi

  • Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome

    Somaia E. Elsheikh;Andrew R. Green;Emad A. Rakha;Des G. Powe

  • Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.

    Suzanne A. Eccles;Eric O. Aboagye;Simak Ali;Annie S. Anderson

  • Phyllodes tumours of the breast: a consensus review

    Benjamin Y. Tan;Geza Acs;Sophia K. Apple;Sunil Badve

  • Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

    E A Rakha;T C Putti;D M Abd El-Rehim;C Paish

  • Biologic and Clinical Characteristics of Breast Cancer With Single Hormone Receptor–Positive Phenotype

    Emad A. Rakha;Maysa E. El-Sayed;Andrew R. Green;E. Claire Paish

  • Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer.

    Emad A Rakha;Richard W G Boyce;Dalia Abd El-Rehim;Thomas Kurien

  • Triple-negative/basal-like breast cancer: review

    Emad A. Rakha;Ian O. Ellis

  • Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis

    Thomas C Putti;Dalia M Abd El-Rehim;Emad A Rakha;Claire E Paish

  • The prognostic significance of lymphovascular invasion in invasive breast carcinoma.

    Emad A. Rakha;Stewart Martin;Andrew H. S. Lee;David Morgan

  • Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes.

    Emad A. Rakha;Maysa E. El-Sayed;Desmond G. Powe;Andrew R. Green

Frequent Co-Authors

Ian O. Ellis
Ian O. Ellis University of Nottingham
Andrew R. Green
Andrew R. Green University of Nottingham
Jorge S. Reis-Filho
Jorge S. Reis-Filho Memorial Sloan Kettering Cancer Center
Ritu Aneja
Ritu Aneja University of Alabama at Birmingham
Carlos Caldas
Carlos Caldas University of Cambridge
Sarah E Pinder
Sarah E Pinder King's College London
Andrew Evans
Andrew Evans University of Dundee
Puay Hoon Tan
Puay Hoon Tan Duke NUS Graduate Medical School
Stephen B. Fox
Stephen B. Fox Peter MacCallum Cancer Centre
Jonathan M. Garibaldi
Jonathan M. Garibaldi University of Nottingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in Medicine but looking for flexible ways to advance your career, pursuing an online healthcare degree may be the ideal solution. Healthcare is a broad field with diverse career opportunities beyond the traditional MD path.

For nurses keen on specialization, accelerated msn psychiatric np programs offer a quick route to becoming a Psychiatric Mental Health Nurse Practitioner. This can open doors to in-demand roles in mental health care.

Those interested in the administrative side of healthcare may consider a health administration degree online. These programs equip students with leadership and management skills vital for running medical organizations.

For advanced positions, affordable online mha programs present a practical pathway to a master’s degree, often at a reduced cost and with flexible schedules to suit working professionals.

Nurses aiming for the highest level of clinical practice should explore msn to dnp programs online. These Doctor of Nursing Practice pathways prepare graduates for leadership, research, and specialty care roles in today’s healthcare landscape.

Best Scientists Citing Emad A. Rakha

Trending Scientists

Recently Published Articles